World Of Taxonomy
0002-7026Level 3

JAYPIRCA (pirtobrutinib)

**Product type:** Human Prescription Drug

**Active ingredient:** PIRTOBRUTINIB

**Strength:** 100 mg/1

**Dosage form:** Tablet, Coated

**Route:** Oral

**Labeler:** Eli Lilly and Company

**Marketing category:** NDA (NDA216059)

**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Bruton's Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/0002-7026
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.